| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 509038 | Voltaire Leasing Voltaire Leasing & Finance Ltd | 03-Nov-2026 | Voltaire Leasing & Finance Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve Unaudited Financial Results for QE/HYE Sept 2026 |
| 540153 | Endurance Tech. Endurance Technologies Ltd | 03-Nov-2026 | Endurance Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve A meeting of the Board of Directors is Scheduled on 3rd November 2026 to consider and approve the unaudited financial results for the quarter and half year ending 30th September 2026. |
| 539542 | Lux Industries Lux Industries Ltd | 03-Nov-2026 | Lux Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2026. |
| 540789 | Diligent Media Diligent Media Corporation Ltd | 03-Nov-2026 | Diligent Media Corporation Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve financial results for Second quarter and half year ended September 30 2026 |
| 544801 | GSPL Transmission GSPL Transmission Ltd | 03-Nov-2026 | GSPL Transmission Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve un-audited financial results for the Quarter and Half Year ended 30th September, 2026 |
| 544700 | Fractal Analyt. Fractal Analytics Ltd | 03-Nov-2026 | Fractal Analytics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ending September 30 2026. |
| 544647 | Nephrocare Health Services Nephrocare Health Services Ltd | 03-Nov-2026 | Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2026. |
| 544937 | NSE National Stock Exchange Of India Ltd | 03-Nov-2026 | Quarterly Results National Stock Exchange Of India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve audited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026. |
| 544210 | Emcure Pharma Emcure Pharmaceuticals Ltd | 03-Nov-2026 | Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30 2026 |
| 543533 | eMudhra eMudhra Ltd | 04-Nov-2026 | Emudhra Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve unaudited Standalone And Consolidated Financial Results of The Company for The Quarter Ended September 30, 2026 |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
